Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
An excitatory synapse is the junction between two neurons at which neurotransmitter release (predominantly glutamate in the CNS) increases the probability of action potential generation in the postsynaptic neuron[1][3][6][8]. It consists of a presynaptic terminal that releases excitatory neurotransmitter, a postsynaptic membrane densely populated with receptors (such as AMPA and NMDA receptors), and associated protein scaffolds (postsynaptic density)[1][3]. The function and density of excitatory synapses are critical for brain signaling, plasticity, and learning. Dysregulation or loss of excitatory synaptic function is implicated in multiple brain disorders[3][7]. For structured information or direct therapeutic relevance, one should specify a particular molecular target or protein within the excitatory synapse (such as "Glutamate receptor subunit NMDA type 2B" or "Postsynaptic density protein 95") rather than referring to the synapse as a whole[3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Excitatory synapse.